Abacus Life (NASDAQ:ABL – Get Free Report) is anticipated to issue its quarterly earnings data after the market closes on Thursday, March 27th. Analysts expect the company to announce earnings of $0.14 per share and revenue of $28.76 million for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.
Abacus Life Stock Down 2.3 %
Shares of NASDAQ:ABL opened at $7.35 on Wednesday. The business’s 50-day moving average is $7.62 and its 200-day moving average is $8.33. Abacus Life has a 1 year low of $6.75 and a 1 year high of $12.50. The company has a market capitalization of $710.34 million, a price-to-earnings ratio of -40.83 and a beta of 0.14. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.29 and a quick ratio of 1.29.
Wall Street Analysts Forecast Growth
Separately, B. Riley cut their price target on Abacus Life from $17.00 to $15.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Five research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $14.30.
About Abacus Life
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Featured Articles
- Five stocks we like better than Abacus Life
- What Investors Need to Know About Upcoming IPOs
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Growth Stocks: What They Are, What They Are Not
- NVIDIA Insiders Sell: This Is What It Means for the MarketÂ
- How to Invest in Biotech Stocks
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.